Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fraud complaints about supplements spike

This article was originally published in The Tan Sheet

Executive Summary

Consumers filed more than three times as many fraud complaints with the Federal Trade Commission about dietary supplements and herbal remedies in 2009 than in 2008, the commission says. FTC received 3,060 complaints about supplements in 2009 compared to 943 in 2008, according to FTC's Consumer Sentinel Network Data Book released in February. Food and drug attorney Marc Ullman speculates that increase "has something to do with the constant harping about 'unregulated,' 'loosely-regulated,' 'under-regulated,' 'steroid-ridden'" supplements in the media (1"The Tan Sheet" Dec. 7, 2009). Ullman, with the New York firm Ullman, Shapiro & Ullman, adds FTC will continue to scrutinize heavily supplements and herbals going forward "as evidenced by the commission's recent warning letters to omega-3 marketers" (2"The Tan Sheet" Feb. 22, 2009). Fraud complaints about OTC and Rx drugs also jumped 87 percent to 1,396 in 2009 compared to the previous year, according to FTC


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts